Stocks · Health care · Pharmaceutical Preparations

Roivant Sciences Ltd.

ROIV Clue Score19
Bermuda Fiscal year ends March CIK 0001635088
35.44
+3.60%
Close, 9 Oct 2026 · USD

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close
35.44 on 9 Oct 2026
42 29 16 Oct 2025 Apr 2026 Oct 2026 13 Oct 2025 $16.21 14 Oct 2025 $16.40 15 Oct 2025 $16.99 16 Oct 2025 $17.11 17 Oct 2025 $17.26 20 Oct 2025 $17.74 21 Oct 2025 $17.87 22 Oct 2025 $17.96 23 Oct 2025 $18.12 24 Oct 2025 $18.22 27 Oct 2025 $18.81 28 Oct 2025 $18.41 29 Oct 2025 $18.76 30 Oct 2025 $19.58 31 Oct 2025 $19.99 3 Nov 2025 $19.60 4 Nov 2025 $19.87 5 Nov 2025 $20.23 6 Nov 2025 $20.57 7 Nov 2025 $20.62 10 Nov 2025 $21.17 11 Nov 2025 $20.90 12 Nov 2025 $21.32 13 Nov 2025 $20.56 14 Nov 2025 $20.29 17 Nov 2025 $20.56 18 Nov 2025 $20.52 19 Nov 2025 $20.34 20 Nov 2025 $20.27 21 Nov 2025 $20.22 24 Nov 2025 $20.30 25 Nov 2025 $20.86 26 Nov 2025 $20.87 28 Nov 2025 $20.81 1 Dec 2025 $20.22 2 Dec 2025 $20.10 3 Dec 2025 $20.70 4 Dec 2025 $21.18 5 Dec 2025 $20.97 8 Dec 2025 $20.99 9 Dec 2025 $20.43 10 Dec 2025 $20.24 11 Dec 2025 $21.34 12 Dec 2025 $22.10 15 Dec 2025 $21.90 16 Dec 2025 $22.94 17 Dec 2025 $22.70 18 Dec 2025 $21.79 19 Dec 2025 $22.41 22 Dec 2025 $22.68 23 Dec 2025 $22.45 24 Dec 2025 $22.50 26 Dec 2025 $22.23 29 Dec 2025 $21.70 30 Dec 2025 $21.63 31 Dec 2025 $21.70 2 Jan 2026 $21.93 5 Jan 2026 $21.30 6 Jan 2026 $21.61 7 Jan 2026 $21.98 8 Jan 2026 $21.78 9 Jan 2026 $21.98 12 Jan 2026 $22.16 13 Jan 2026 $23.44 14 Jan 2026 $23.81 15 Jan 2026 $23.30 16 Jan 2026 $23.13 20 Jan 2026 $22.98 21 Jan 2026 $22.98 22 Jan 2026 $22.97 23 Jan 2026 $22.58 26 Jan 2026 $22.73 27 Jan 2026 $22.53 28 Jan 2026 $21.91 29 Jan 2026 $22.02 30 Jan 2026 $21.62 2 Feb 2026 $21.94 3 Feb 2026 $21.97 4 Feb 2026 $21.65 5 Feb 2026 $21.14 6 Feb 2026 $25.82 9 Feb 2026 $27.67 10 Feb 2026 $27.35 11 Feb 2026 $26.80 12 Feb 2026 $26.75 13 Feb 2026 $26.45 17 Feb 2026 $27.09 18 Feb 2026 $27.48 19 Feb 2026 $27.52 20 Feb 2026 $27.15 23 Feb 2026 $27.76 24 Feb 2026 $28.26 25 Feb 2026 $28.66 26 Feb 2026 $28.49 27 Feb 2026 $28.94 2 Mar 2026 $28.10 3 Mar 2026 $27.85 4 Mar 2026 $29.52 5 Mar 2026 $29.72 6 Mar 2026 $28.78 9 Mar 2026 $29.53 10 Mar 2026 $29.70 11 Mar 2026 $29.58 12 Mar 2026 $28.55 13 Mar 2026 $28.06 16 Mar 2026 $28.28 17 Mar 2026 $28.30 18 Mar 2026 $27.80 19 Mar 2026 $27.80 20 Mar 2026 $27.70 23 Mar 2026 $27.93 24 Mar 2026 $26.87 25 Mar 2026 $27.36 26 Mar 2026 $27.35 27 Mar 2026 $26.52 30 Mar 2026 $26.41 31 Mar 2026 $27.70 1 Apr 2026 $27.84 2 Apr 2026 $28.33 6 Apr 2026 $27.88 7 Apr 2026 $27.75 8 Apr 2026 $28.17 9 Apr 2026 $28.48 10 Apr 2026 $28.21 13 Apr 2026 $28.95 14 Apr 2026 $29.12 15 Apr 2026 $29.39 16 Apr 2026 $29.19 17 Apr 2026 $29.83 20 Apr 2026 $29.08 21 Apr 2026 $29.29 22 Apr 2026 $29.15 23 Apr 2026 $28.14 24 Apr 2026 $27.41 27 Apr 2026 $27.85 28 Apr 2026 $27.77 29 Apr 2026 $27.52 30 Apr 2026 $28.53 1 May 2026 $27.83 4 May 2026 $28.36 5 May 2026 $28.32 6 May 2026 $28.82 7 May 2026 $28.28 8 May 2026 $28.56 11 May 2026 $28.96 12 May 2026 $29.39 13 May 2026 $29.22 14 May 2026 $29.50 15 May 2026 $29.29 18 May 2026 $28.55 19 May 2026 $28.21 20 May 2026 $32.41 21 May 2026 $30.88 22 May 2026 $29.96 26 May 2026 $29.67 27 May 2026 $29.58 28 May 2026 $29.88 29 May 2026 $29.99 1 Jun 2026 $29.09 2 Jun 2026 $28.25 3 Jun 2026 $28.70 4 Jun 2026 $29.53 5 Jun 2026 $28.58 8 Jun 2026 $28.49 9 Jun 2026 $29.05 10 Jun 2026 $28.41 11 Jun 2026 $29.73 12 Jun 2026 $30.04 15 Jun 2026 $30.03 16 Jun 2026 $30.41 17 Jun 2026 $31.20 18 Jun 2026 $31.43 22 Jun 2026 $31.25 23 Jun 2026 $32.21 24 Jun 2026 $34.01 25 Jun 2026 $34.02 26 Jun 2026 $34.07 29 Jun 2026 $34.73 30 Jun 2026 $35.39 1 Jul 2026 $35.03 2 Jul 2026 $35.13 6 Jul 2026 $35.39 7 Jul 2026 $36.31 8 Jul 2026 $36.09 9 Jul 2026 $36.81 10 Jul 2026 $35.97 13 Jul 2026 $34.51 14 Jul 2026 $34.91 15 Jul 2026 $34.89 16 Jul 2026 $33.93 17 Jul 2026 $34.51 20 Jul 2026 $34.05 21 Jul 2026 $34.96 22 Jul 2026 $34.91 23 Jul 2026 $35.10 24 Jul 2026 $35.01 27 Jul 2026 $34.72 28 Jul 2026 $33.84 29 Jul 2026 $32.87 30 Jul 2026 $34.52 31 Jul 2026 $33.91 3 Aug 2026 $33.32 4 Aug 2026 $34.59 5 Aug 2026 $34.60 6 Aug 2026 $35.12 7 Aug 2026 $36.34 10 Aug 2026 $35.78 11 Aug 2026 $35.25 12 Aug 2026 $36.16 13 Aug 2026 $36.28 14 Aug 2026 $36.20 17 Aug 2026 $36.24 18 Aug 2026 $37.37 19 Aug 2026 $37.40 20 Aug 2026 $36.84 21 Aug 2026 $36.30 24 Aug 2026 $36.36 25 Aug 2026 $36.47 26 Aug 2026 $36.75 27 Aug 2026 $37.58 28 Aug 2026 $34.71 31 Aug 2026 $34.64 1 Sep 2026 $34.52 2 Sep 2026 $34.18 3 Sep 2026 $34.41 4 Sep 2026 $34.93 8 Sep 2026 $41.48 9 Sep 2026 $41.81 10 Sep 2026 $40.94 11 Sep 2026 $40.82 14 Sep 2026 $41.02 15 Sep 2026 $39.50 16 Sep 2026 $39.57 17 Sep 2026 $39.98 18 Sep 2026 $39.77 21 Sep 2026 $38.99 22 Sep 2026 $38.22 23 Sep 2026 $36.82 24 Sep 2026 $36.13 25 Sep 2026 $35.80 28 Sep 2026 $36.98 29 Sep 2026 $36.50 30 Sep 2026 $36.57 1 Oct 2026 $35.50 2 Oct 2026 $35.72 5 Oct 2026 $35.78 6 Oct 2026 $35.53 7 Oct 2026 $34.75 8 Oct 2026 $34.21 9 Oct 2026 $35.44 Venker Eric President & Immunovant CEO Sold on a plan $336.81K 13 Oct 2025 · at $16.25 · 1.4% of stake Venker Eric President & Immunovant CEO Sold on a plan $7.02M 15 Oct 2025 · at $16.93 · 21.6% of stake Venker Eric President & Immunovant CEO Sold on a plan $5.43M 16 Oct 2025 · at $17.05 · 17.5% of stake Venker Eric President & Immunovant CEO Sold on a plan $2.02M 17 Oct 2025 · at $17.06 · 7.3% of stake Venker Eric President & Immunovant CEO Sold on a plan $4.04M 7 Nov 2025 · at $20.22 · 11.7% of stake Ramaswamy Vivek 10% owner Sold at will $5.98M 13 Nov 2025 · at $20.81 · 0.8% of stake Ramaswamy Vivek 10% owner Sold at will $20.89M 14 Nov 2025 · at $20.33 · 2.9% of stake Ramaswamy Vivek 10% owner Sold at will $11.07M 17 Nov 2025 · at $20.51 · 1.6% of stake MANCHESTER KEITH S Director Sold at will $26.30M 19 Nov 2025 · at $20.23 · 6.7% of stake Gold Daniel Allen Director Sold at will $26.30M 19 Nov 2025 · at $20.23 · 6.7% of stake QVT Financial LP Director by Deputization Sold at will $26.30M 19 Nov 2025 · at $20.23 · 6.7% of stake Venker Eric President & Immunovant CEO Sold on a plan $4.17M 9 Dec 2025 · at $20.85 · 11.8% of stake Ramaswamy Vivek 10% owner Sold at will $16.75M 11 Dec 2025 · at $21.64 · 2.2% of stake Ramaswamy Vivek 10% owner Sold at will $43.39M 12 Dec 2025 · at $21.96 · 5.2% of stake Ramaswamy Vivek 10% owner Sold at will $7.80M 15 Dec 2025 · at $22.05 · 1.0% of stake Gline Matthew CEO Sold at will $37.72M 15 Dec 2025 · at $21.68 · 9.1% of stake Gold Daniel Allen Director Sold at will $21.13M 16 Dec 2025 · at $23.04 · 5.1% of stake MANCHESTER KEITH S Director Sold at will $21.13M 16 Dec 2025 · at $23.04 · 5.1% of stake QVT Financial LP Director by Deputization Sold at will $21.13M 16 Dec 2025 · at $23.04 · 5.1% of stake Sukhatme Mayukh President & CIO Sold at will $619.53K 17 Dec 2025 · at $23.09 · 0.1% of stake QVT Financial LP Director by Deputization Sold at will $17.94M 17 Dec 2025 · at $23.07 · 4.5% of stake MANCHESTER KEITH S Director Sold at will $17.94M 17 Dec 2025 · at $23.07 · 4.5% of stake Gold Daniel Allen Director Sold at will $17.94M 17 Dec 2025 · at $23.07 · 4.5% of stake Venker Eric President & Immunovant CEO Sold at will $4.49M 23 Dec 2025 · at $22.45 · 11.0% of stake Pulik Richard CFO Sold at will $9.12M 23 Dec 2025 · at $22.43 · 62.9% of stake Venker Eric President & Immunovant CEO Sold at will $1.69M 24 Dec 2025 · at $22.53 · 4.3% of stake Sukhatme Mayukh President & CIO Sold at will $6.78M 29 Dec 2025 · at $21.74 · 1.6% of stake Sukhatme Mayukh President & CIO Sold at will $22.12M 31 Dec 2025 · at $21.71 · 4.8% of stake Venker Eric President & Immunovant CEO Sold on a plan $4.38M 12 Jan 2026 · at $21.92 · 10.8% of stake Sukhatme Mayukh President & CIO Sold at will $8.99M 9 Feb 2026 · at $26.47 · 1.7% of stake QVT Financial LP Director by Deputization Sold at will $11.33M 11 Feb 2026 · at $26.67 · 2.6% of stake Gold Daniel Allen Director Sold at will $11.33M 11 Feb 2026 · at $26.67 · 2.6% of stake MANCHESTER KEITH S Director Sold at will $11.33M 11 Feb 2026 · at $26.67 · 2.6% of stake MANCHESTER KEITH S Director Sold at will $11.37M 12 Feb 2026 · at $26.75 · 2.7% of stake Gold Daniel Allen Director Sold at will $11.37M 12 Feb 2026 · at $26.75 · 2.7% of stake QVT Financial LP Director by Deputization Sold at will $11.37M 12 Feb 2026 · at $26.75 · 2.7% of stake Venker Eric President & Immunovant CEO Sold on a plan $5.30M 13 Feb 2026 · at $26.49 · 10.8% of stake MANCHESTER KEITH S Director Sold at will $9.96M 13 Feb 2026 · at $26.50 · 2.4% of stake Gold Daniel Allen Director Sold at will $9.96M 13 Feb 2026 · at $26.50 · 2.4% of stake QVT Financial LP Director by Deputization Sold at will $9.96M 13 Feb 2026 · at $26.50 · 2.4% of stake Torti Frank President and Vant Chair Sold on a plan $38.39M 19 Feb 2026 · at $27.42 · 9.2% of stake Torti Frank President and Vant Chair Sold on a plan $27.49M 20 Feb 2026 · at $27.15 · 6.9% of stake Torti Frank President and Vant Chair Sold on a plan $16.16M 23 Feb 2026 · at $27.51 · 4.1% of stake Epperly Melissa B, Director Sold at will $1.20M 16 Mar 2026 · at $28.68 · 72.6% of stake Venker Eric President & Immunovant CEO Sold on a plan $5.65M 17 Mar 2026 · at $28.24 · 10.8% of stake Fitzgerald Meghan Director Sold at will $1.92M 26 Mar 2026 · at $27.45 · 62.0% of stake Humes Jennifer Chief Accounting Officer Sold at will $384.07K 8 Apr 2026 · at $28.37 · 13.9% of stake Gline Matthew CEO Sold at will $8.45M 16 Apr 2026 · at $29.16 · 1.7% of stake Venker Eric President & Immunovant CEO Sold on a plan $5.92M 20 Apr 2026 · at $29.59 · 10.8% of stake Venker Eric President & Immunovant CEO Sold on a plan $6.05M 22 May 2026 · at $30.27 · 11.0% of stake Venker Eric President & Immunovant CEO Sold on a plan $6.63M 24 Jun 2026 · at $33.16 · 11.0% of stake Sukhatme Mayukh President & CIO Sold at will $17.07M 25 Jun 2026 · at $34.13 · 2.6% of stake Sukhatme Mayukh President & CIO Sold at will $17.04M 26 Jun 2026 · at $34.08 · 2.6% of stake MANCHESTER KEITH S Director Sold at will $21.28M 26 Jun 2026 · at $34.00 · 4.1% of stake Gold Daniel Allen Director Sold at will $21.28M 26 Jun 2026 · at $34.00 · 4.1% of stake QVT Financial LP Director by Deputization Sold at will $21.28M 26 Jun 2026 · at $34.00 · 4.1% of stake Epperly Melissa B, Director Sold on a plan $610.25K 29 Jun 2026 · at $34.38 · 51.9% of stake Gold Daniel Allen Director Sold at will $27.64M 29 Jun 2026 · at $34.55 · 5.5% of stake MANCHESTER KEITH S Director Sold at will $27.64M 29 Jun 2026 · at $34.55 · 5.5% of stake QVT Financial LP Director by Deputization Sold at will $27.64M 29 Jun 2026 · at $34.55 · 5.5% of stake Fitzgerald Meghan Director Sold on a plan $349.00K 30 Jun 2026 · at $34.90 · 18.9% of stake MANCHESTER KEITH S Director Sold at will $436.77K 30 Jun 2026 · at $35.28 · 0.1% of stake Gold Daniel Allen Director Sold at will $436.77K 30 Jun 2026 · at $35.28 · 0.1% of stake QVT Financial LP Director by Deputization Sold at will $436.77K 30 Jun 2026 · at $35.28 · 0.1% of stake MANCHESTER KEITH S Director Sold at will $7.09M 30 Jun 2026 · at $35.45 · 10.3% of stake Venker Eric President & Immunovant CEO Sold on a plan $6.99M 27 Jul 2026 · at $34.95 · 11.0% of stake Sukhatme Mayukh President & CIO Sold at will $8.81M 14 Aug 2026 · at $36.23 · 1.3% of stake Sukhatme Mayukh President & CIO Sold at will $10.32M 17 Aug 2026 · at $36.25 · 1.5% of stake Sukhatme Mayukh President & CIO Sold at will $5.03M 18 Aug 2026 · at $36.73 · 0.7% of stake Sukhatme Mayukh President & CIO Sold at will $6.43M 19 Aug 2026 · at $37.17 · 0.9% of stake Sukhatme Mayukh President & CIO Sold at will $653.46K 20 Aug 2026 · at $37.30 · 0.1% of stake Sukhatme Mayukh President & CIO Sold at will $5.28M 21 Aug 2026 · at $36.48 · 0.8% of stake Venker Eric President & Immunovant CEO Sold on a plan $7.15M 28 Aug 2026 · at $35.77 · 11.1% of stake Fitzgerald Meghan Director Sold on a plan $798.00K 8 Sep 2026 · at $39.90 · 31.8% of stake Epperly Melissa B, Director Sold on a plan $196.23K 15 Sep 2026 · at $39.74 · 33.3% of stake Fitzgerald Meghan Director Sold on a plan $203.15K 15 Sep 2026 · at $39.74 · 12.4% of stake Venker Eric President & Immunovant CEO Sold on a plan $7.32M 30 Sep 2026 · at $36.62 · 11.1% of stake Epperly Melissa B, Director Sold on a plan $640.86K 1 Oct 2026 · at $36.10 · 54.3% of stake
0 buys54 sales at will24 planned sales

Key numbers

Fiscal year 2026, ended 31 Mar 2026, as filed
Revenue
$8.26M
Net income
$299.77M
Free cash flow
$758.56M
Operating margin
-6,235.7%
Net margin
-3,629.2%
Return on equity
-6.6%
Return on capital
-8.4%
Debt to equity
0.07
Revenue growth, 1 yr
-71.6%
Revenue growth, 5 yr
-19.1% a year

Revenue and net income

Fiscal years, as filed with the SEC · point at a year for the detail
24M -809M FY21 Fiscal year 2021 Revenue $23.80M Net income $809.23M Margin -3,400.9% 55M -845M FY22 Fiscal year 2022 Revenue $55.29M Net income $845.26M Margin -1,528.9% · growth +132.3% 32M -1B FY23 Fiscal year 2023 Revenue $31.53M Net income $1.01B Margin -3,200.2% · growth -43.0% 33M 4.3B FY24 Fiscal year 2024 Revenue $32.71M Net income $4.35B Margin 13,294.2% · growth +3.8% 29M -172M FY25 Fiscal year 2025 Revenue $29.05M Net income $171.98M Margin -592.0% · growth -11.2% 8M -300M FY26 Fiscal year 2026 Revenue $8.26M Net income $299.77M Margin -3,629.2% · growth -71.6%
RevenueNet incomeLoss

Latest insider transactions

From Form 4, most recent first
All of them →
DateInsiderTypeValueOf own stake
1 Oct 2026 Epperly Melissa B,
Director
Sold on a plan $640.86K 54.3%
30 Sep 2026 Venker Eric
President & Immunovant CEO
Sold on a plan $7.32M 11.1%
15 Sep 2026 Fitzgerald Meghan
Director
Sold on a plan $203.15K 12.4%
15 Sep 2026 Epperly Melissa B,
Director
Sold on a plan $196.23K 33.3%
8 Sep 2026 Fitzgerald Meghan
Director
Sold on a plan $798.00K 31.8%
28 Aug 2026 Venker Eric
President & Immunovant CEO
Sold on a plan $7.15M 11.1%